Jennifer Chu

Jennifer Chu received her B.S.E. (Princeton University) and Ph.D. (University of Texas, Austin) before spending 7 years at Pfizer (as a Senior Principal Scientist) followed by work at a series of small biotech companies (Neurogen, Ikaria, Achillion as an Executive Director of Pharmaceutical Sciences). She joined FreeThink in 2018 where she leads formulation development and manages FreeThink’s new technology development.